Economics and Precision Medicine

Research output: Contribution to journalArticlepeer-review

Abstract

Introducing precision medicine strategies into routine practice will require robust economic evidence. Decision-makers need to understand the value of a precision medicine strategy compared with alternative ways to treat patients. This chapter describes health economic analysis techniques that are needed to generate this evidence. The value of any precision medicine strategy can be demonstrated early to inform evidence generation and improve the likelihood of translation into routine practice. Advances in health economic analysis techniques are also explained and their relevance to precision medicine is highlighted. Ensuring that constraints on delivery are resolved to increase uptake and implementation will improve the value of a new precision medicine strategy. Empirical methods to quantify stakeholders’ preferences can be effective to inform the design of a precision medicine intervention or service delivery model. A range of techniques to generate relevant economic evidence are now available to support the development and translation of precision medicine into routine practice. This economic evidence is essential to inform resource allocation decisions and will enable patients to benefit from cost-effective precision medicine strategies in the future.
Original languageEnglish
Pages (from-to)1-19
Number of pages19
JournalHandbook of Experimental Pharmacology
DOIs
Publication statusPublished - 30 Jun 2022

Keywords

  • Budget impact analysis
  • Cost-effectiveness analysis
  • Decision-analytic model
  • Discrete choice experiment
  • Economic evaluation
  • Microcosting
  • Pharmacoeconomics
  • Stated preferences
  • Value of implementation
  • Value of information

Fingerprint

Dive into the research topics of 'Economics and Precision Medicine'. Together they form a unique fingerprint.

Cite this